Search PubMedSearch

PubMed · 6985116

[Diffuse nonautoimmune hyperthyroidism].

Abstract

Diffuse non auto-immune hyperthyroidism is a rare entity, classically restricted to cases with hypersecretion of TSH, hCG or related molecule and to a few reports of proven paraneoplastic origin. The authors try to individualize another type of diffuse hyperthyroidism, previously considered to belong to Graves' disease, but without any sign of disimmunity. They present a familial form with several hyperthyroidic patients who showed neither change in humoral immunity nor immunological abnormality within the thyroid gland, even in those that were operated upon without prior antithyroid medication. Similar findings occurred within several series of hyperthyroid glands separately studied by the authors, using different techniques: histomorphometric quantification of lymphocytic infiltration, immunofluorescence in the search of IgG, IgA, IgM, C1 q, C3 and C9 fractions, or T-lymphocyte subsets. These techniques generally tend to yield positive results, that agree with an auto-immune pathogenesis, but totally negative findings do occur. This type of diffuse hyperthyroidism should be delineated from the common auto-immune type, and might be called toxic hyperplasia.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Leclere, J L Thomas. 1982. [Diffuse nonautoimmune hyperthyroidism].. https://pubmed.ncbi.nlm.nih.gov/6985116/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Antigen-binding B cells and polyreactive antibodies.

The present experiments were initiated to see if cells capable of binding antigens could make polyreactive antibodies. Fluorescein isothiocyanate-labeled self and non-self antigens were incubated with B cells from normal individuals. Antigen-binding cells were separated from non-antigen-binding cells by flow cytometry, immortalized with Epstein-Barr virus and analyzed at the clonal level for their capacity to make polyreactive antibodies. Four to six times more cells making polyreactive antibodies were found in the B cell subset that bound antigens than in the B cell subset that did not bind antigens. The majority of the polyreactive antibodies were of the immunoglobulin (Ig)M isotype. Immunoflow cytometry revealed that cell lines making polyreactive antibodies bound a variety of antigens (e.g., insulin, IgGFc and beta-galactosidase), whereas cell lines making monoreactive antibodies bound only a single antigen. The binding of antigens to B cell lines that made polyreactive antibodies could be inhibited (range, 28%-57%) by both homogeneous and heterogeneous antigens. Both CD5+ and CD5- antigen-binding B cells made polyreactive antibodies, but the frequency was slightly higher in the CD5+ antigen-binding (85%) as compared to the CD5- antigen-binding (50%) population. Comparison of CD5+ B cells that bound antigens with CD5+ B cells that did not bind antigens showed that approximately 86% of the former, but only 15% of the latter, made polyreactive antibodies. It is concluded that cells capable of binding a variety of different antigens can make polyreactive antibodies and that antigen binding is a good marker for identifying polyreactive antibody-producing cells.

Antibody Formation

The humoral immune system in coeliac disease.

IgA is transported into intestinal secretions to perform exclusion of luminal antigens. The prerequisites are antigen sampling by the Peyer's patch M cells, antigen processing by antigen-presenting cells, and presentation of antigenic peptides by HLA class II molecules to immunocompetent T-cells. The basis for intestinal immunity is the maturation cycle of specifically primed T and B cells from the gut-associated lymphoid tissue via mesenteric lymph nodes and peripheral blood back to the intestinal lamina propria. In coeliac disease, patients are sensitized against gluten and serum gliadin antibodies are often detected. Gliadin antibodies are also found in other gastrointestinal diseases, other disorders and in healthy individuals not carrying the coeliac disease-specific DQA/DQB alleles. On the other hand, serum reticulin and endomysium autoantibodies are both sensitive and highly disease-specific. Positivity in patients with normal jejunal morphology indicates latency of coeliac disease. These tissue autoantibodies are directed against fibroblast-derived extracellular matrix proteins. The immune system is involved in the amplification and perpetuation of the abnormalities of the intestinal mucosa in coeliac disease. The role of antibody in the pathogenesis remains unknown. The author hypothesizes gluten-triggered autoimmune mechanism to be operative.

Antibody Formation